PDL BioPharma (PDLI) Misses Q4 EPS, Revs Light
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) reports a Q4 loss of $0.21 (loss of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
